Rx … Mens Sana In Corpore Sano
by Dr. Neville Wilson 30 Jan 2013 Tredaptive was introduced into the European drug market on 3rd July 2008, as a pharmaceutical formulation designed to treat certain forms of mixed dyslipidaemia in patients judged to be at risk of cardiovascular disease. On the basis of…
Dr. Neville S. Wilson. – 15 July 2007. The widely held belief that blood cholesterol levels are potentially harmful and should be lowered in order to prevent heart disease is a product of speculative and persuasive promotion by advocates of what has been called the…
Is it Justifiable to Medicalise Healthy Persons? (THE JUPITER STUDY 2008) A recent ruling by the FDA (Dec 2009) permitted new criteria for the use of the cholesterol lowering drug, CRESTOR (rosuvastatin), thereby sanctioning its use as a preventative agent for healthy persons who may be…